0001209191-22-037111.txt : 20220615 0001209191-22-037111.hdr.sgml : 20220615 20220615191445 ACCESSION NUMBER: 0001209191-22-037111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220613 FILED AS OF DATE: 20220615 DATE AS OF CHANGE: 20220615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROSS HERB CENTRAL INDEX KEY: 0001230721 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38935 FILM NUMBER: 221019008 MAIL ADDRESS: STREET 1: 3061 ZANKER RD CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atreca, Inc. CENTRAL INDEX KEY: 0001532346 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273723255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 835 INDUSTRIAL ROAD, STREET 2: SUITE 400 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-595-2595 MAIL ADDRESS: STREET 1: 835 INDUSTRIAL ROAD, STREET 2: SUITE 400 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-13 0 0001532346 Atreca, Inc. BCEL 0001230721 CROSS HERB C/O ATRECA, INC., 835 INDUSTRIAL RD. SUITE 400 SAN CARLOS CA 94070 0 1 0 0 Chief Financial Officer Employee stock option (right to buy) 1.845 2022-06-13 4 A 0 95000 A 2031-01-26 Class A Common Stock 95000 95000 D Employee stock option (right to buy) 13.97 2022-06-13 4 D 0 95000 0.00 D 2031-01-26 Class A Common Stock 95000 0 D Employee stock option (right to buy) 1.845 2022-06-13 4 A 0 224999 A 2029-04-04 Class A Common Stock 224999 224999 D Employee stock o16.74ption (right to buy) 12.06 2022-06-13 4 D 0 224999 0.00 D 2029-04-04 Class A Common Stock 224999 0 D Employee stock option (right to buy) 1.845 2022-06-13 4 A 0 97000 A 2030-02-25 Class A Common Stock 97000 97000 D Employee stock option (right to buy) 22.07 2022-06-13 4 D 0 97000 0.00 D 2030-02-25 Class A Common Stock 97000 0 D 1/48 of the Option vests in equal monthly installments as measured from 1/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time. The transactions reported herein reflect a one-time stock option repricing effective on June 13, 2022 (the "Option Repricing"). The Option Repricing applies to options with exercise prices greater than or equal to $9.00 per share held by all employees of the Issuer as of June 13, 2022. Pursuant to the Option Repricing, the exercise price of the repriced options, including the Option, has been amended to reduce the exercise price to $1.845 per share, the closing price of the Issuer's Class A common stock on the Nasdaq Global Select Market as of the date of the Option Repricing. There have been no other changes to the terms of the repriced options, including the Option. The Option Repricing does not apply to options held by non-employee directors of the Issuer. 1/4 of the Option vests on 2/25/2020 and 1/48 of the Option vests in equal monthly installments as measured from 2/25/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time. 2/48 of the Option vests on 3/1/2020 and 1/48 of the Option vests in equal monthly installments as measured from 3/1/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time. /s/ Herbert Cross 2022-06-15